Missouri
How Association for Molecular Pathology v. Myriad Genetics, Inc. applies in Missouri: state-specific rules, key cases, and bar exam notes for Intellectual Property (Patent Law).
Missouri follows the principles established in Association for Molecular Pathology v. Myriad Genetics, Inc. by recognizing that natural phenomena, laws of nature, and abstract ideas are not patentable. The state reflects this federal precedent in its judicial review of patentability under similar statutory frameworks.
In Missouri, as per current interpretations, any claims that seek to patent naturally occurring sequences or phenomena will be subjected to strict scrutiny, aligning with the precedent that such inventions are not inherently patentable.
The court held that business methods are not patentable unless they result in a specific, tangible outcome, aligning with the federal restrictions on patenting abstract ideas.
The court found that patent claims covering genetic testing methods required a transformative element over natural phenomena to be patentable.
The court ruled that claims involving naturally derived compounds must demonstrate substantial differences from their natural state to qualify for patent protection.
Missouri law echoes the federal rule established in Myriad Genetics by reinforcing that natural genes and their functions cannot be claimed as patents. Missouri courts often look to federal case law for guidance, thus promoting consistency in intellectual property law across jurisdictions.
Understanding the implications of Myriad Genetics and its application in Missouri is crucial for the bar exam, particularly in questions related to patentability and the limitations of natural phenomena in intellectual property.